{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:28:57Z","timestamp":1791523737700,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT100237"],"award-info":[{"award-number":["WT100237"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biotechnology and Biological Sciences Research Council Project Grant","award":["BB\/J009598\/1"],"award-info":[{"award-number":["BB\/J009598\/1"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.tips.2016.12.006","type":"journal-article","created":{"date-parts":[[2017,1,28]],"date-time":"2017-01-28T01:31:24Z","timestamp":1485567084000},"page":"363-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"title":["Targeting Class I Histone Deacetylases in a \u201cComplex\u201d Environment"],"prefix":"10.1016","volume":"38","author":[{"given":"Christopher J.","family":"Millard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Fairall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.R.","family":"Schwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2016.12.006_bib0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"35","author":"Kilgore","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2016.12.006_bib0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2016.12.006_bib0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nchembio815","article-title":"Histone deacetylase inhibitors reverse gene silencing in Friedreich\u2019s ataxia","volume":"2","author":"Herman","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-7-10","article-title":"HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation","volume":"7","author":"Nural-Guvener","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.tips.2016.12.006_bib0025","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tips.2016.12.006_bib0030","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1158\/1078-0432.CCR-15-0530","article-title":"Panobinostat for the treatment of multiple myeloma","volume":"21","author":"Laubach","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tips.2016.12.006_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5582\/irdr.2016.01024","article-title":"Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China","volume":"5","author":"Lu","year":"2016","journal-title":"IRDR"},{"key":"10.1016\/j.tips.2016.12.006_bib0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13148-010-0012-4","article-title":"Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy","volume":"1","author":"Wagner","year":"2010","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.tips.2016.12.006_bib0045","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","article-title":"Clinical toxicities of histone deacetylase inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.tips.2016.12.006_bib0050","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.drudis.2015.01.007","article-title":"Histone deacetylases: structural determinants of inhibitor selectivity","volume":"20","author":"Micelli","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2016.12.006_bib0055","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.drudis.2015.01.004","article-title":"How the flexibility of human histone deacetylases influences ligand binding: an overview","volume":"20","author":"Deschamps","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2016.12.006_bib0060","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.chembiol.2016.06.011","article-title":"Innovative strategies for selective inhibition of histone deacetylases","volume":"23","author":"Maolanon","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2016.12.006_bib0070","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.tips.2016.12.006_bib0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ja.2011.35","article-title":"Romidepsin (I stodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma","volume":"64","author":"VanderMolen","year":"2011","journal-title":"J. Antibiot."},{"key":"10.1016\/j.tips.2016.12.006_bib0080","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40265-014-0275-8","article-title":"Belinostat: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2016.12.006_bib0085","first-page":"84","article-title":"Farydak (Panobinostat): first HDAC inhibitor approved for patients with relapsed multiple myeloma","volume":"9","author":"Raedler","year":"2016","journal-title":"Am. Health Drug Benefits"},{"key":"10.1016\/j.tips.2016.12.006_bib0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4155\/fmc.12.3","article-title":"Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed","volume":"4","author":"Gryder","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0095","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1158\/1535-7163.MCT-11-0433","article-title":"Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma","volume":"10","author":"Hideshima","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tips.2016.12.006_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.seminhematol.2007.11.007","article-title":"DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes","volume":"45","author":"Griffiths","year":"2008","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.tips.2016.12.006_bib0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2016.12.006_bib0110","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.96.8.4592","article-title":"A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors","volume":"96","author":"Saito","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2016.12.006_bib0115","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.103.055541","article-title":"Identification of novel isoform-selective inhibitors within class I histone deacetylases","volume":"307","author":"Hu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2016.12.006_bib0120","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/npp.2015.93","article-title":"Pharmacological selectivity within class I histone deacetylases predicts effects on synaptic function and memory rescue","volume":"40","author":"Rumbaugh","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2016.12.006_bib0125","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability","volume":"288","author":"Lauffer","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0130","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.str.2004.04.012","article-title":"Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases","volume":"12","author":"Somoza","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.tips.2016.12.006_bib0135","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.bmcl.2010.03.091","article-title":"Exploration of the HDAC2 foot pocket: synthesis and SAR of substituted N-(2-aminophenyl)benzamides","volume":"20","author":"Bressi","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2016.12.006_bib0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2013.05.020","article-title":"Class I HDACs share a common mechanism of regulation by inositol phosphates","volume":"51","author":"Millard","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature10728","article-title":"Structure of HDAC3 bound to co-repressor and inositol tetraphosphate","volume":"481","author":"Watson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tips.2016.12.006_bib0150","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1021\/jm0498497","article-title":"On the function of the 14\u00c5 long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors","volume":"47","author":"Wang","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0155","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1016\/j.bmc.2011.06.030","article-title":"Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors","volume":"19","author":"Whitehead","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0160","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1021\/ja205972n","article-title":"Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases","volume":"133","author":"Cole","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2016.12.006_bib0165","doi-asserted-by":"crossref","first-page":"11262","DOI":"10.1038\/ncomms11262","article-title":"Insights into the activation mechanism of class I HDAC complexes by inositol phosphates","volume":"7","author":"Watson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2016.12.006_bib0170","doi-asserted-by":"crossref","first-page":"13554","DOI":"10.1021\/bi801610c","article-title":"Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors","volume":"47","author":"Dowling","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2016.12.006_bib0175","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0960-9822(98)70328-8","article-title":"A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase","volume":"8","author":"Wade","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0092-8674(00)81758-4","article-title":"The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities","volume":"95","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0092-8674(00)80214-7","article-title":"Histone deacetylase activity is required for full transcriptional repression by mSin3A","volume":"89","author":"Hassig","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0092-8674(00)80215-9","article-title":"Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression","volume":"89","author":"Laherty","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nbt.1759","article-title":"Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes","volume":"29","author":"Bantscheff","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2016.12.006_bib0200","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/nar\/gkv068","article-title":"Structural and functional characterization of a cell cycle associated HDAC1\/2 complex reveals the structural basis for complex assembly and nucleosome targeting","volume":"43","author":"Itoh","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2016.12.006_bib0205","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1073\/pnas.98.4.1454","article-title":"CoREST is an integral component of the CoREST- human histone deacetylase complex","volume":"98","author":"You","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2016.12.006_bib0210","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/MCB.23.1.250-258.2003","article-title":"Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain","volume":"23","author":"Ding","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0215","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/dvdy.21196","article-title":"REREa\/atrophin-2 interacts with histone deacetylase and Fgf8 signaling to regulate multiple processes of zebrafish development","volume":"236","author":"Plaster","year":"2007","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.tips.2016.12.006_bib0220","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1101\/gad.14.9.1048","article-title":"A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness","volume":"14","author":"Guenther","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.tips.2016.12.006_bib0225","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1073\/pnas.97.13.7202","article-title":"The histone deacetylase-3 complex contains nuclear receptor corepressors","volume":"97","author":"Wen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2016.12.006_bib0230","first-page":"583","article-title":"NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment","volume":"10","author":"Reynolds","year":"2012","journal-title":"Stem Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0235","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrc3091","article-title":"Cancer biology and NuRD: a multifaceted chromatin remodelling complex","volume":"11","author":"Lai","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tips.2016.12.006_bib0240","doi-asserted-by":"crossref","first-page":"e13941","DOI":"10.7554\/eLife.13941","article-title":"The structure of the core NuRD repression complex provides insights into its interaction with chromatin","volume":"5","author":"Millard","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.tips.2016.12.006_bib0245","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/pro.2943","article-title":"The MTA1 subunit of the nucleosome remodeling and deacetylase complex can recruit two copies of RBBP4\/7","volume":"25","author":"Schmidberger","year":"2016","journal-title":"Protein Sci."},{"issue":"July 14","key":"10.1016\/j.tips.2016.12.006_bib0250","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.jmb.2016.04.025","article-title":"The nucleosome remodeling and deacetylase complex NuRD is built from preformed catalytically active sub-modules","volume":"428","author":"Zhang","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0255","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1073\/pnas.96.17.9873","article-title":"CoREST: a functional corepressor required for regulation of neural-specific gene expression","volume":"96","author":"Andres","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2016.12.006_bib0260","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molcel.2006.07.012","article-title":"Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase","volume":"23","author":"Yang","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0265","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1093\/nar\/gkv388","article-title":"Extranucleosomal DNA enhances the activity of the LSD1\/CoREST histone demethylase complex","volume":"43","author":"Kim","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2016.12.006_bib0270","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molcel.2011.05.031","article-title":"Quantitative proteomics reveals the basis for the biochemical specificity of the cell-cycle machinery","volume":"43","author":"Pagliuca","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0275","doi-asserted-by":"crossref","first-page":"35283","DOI":"10.1074\/jbc.M805590200","article-title":"A novel germ cell-specific protein, SHIP1, forms a complex with chromatin remodeling activity during spermatogenesis","volume":"283","author":"Choi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2443.2005.00916.x","article-title":"Direct binding of TReP-132 with TdT results in reduction of TdT activity","volume":"11","author":"Fujisaki","year":"2005","journal-title":"Genes Cells"},{"key":"10.1016\/j.tips.2016.12.006_bib0285","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0092-8674(87)90236-4","article-title":"Both positive and negative regulators of HO transcription are required for mother-cell-specific mating-type switching in yeast","volume":"48","author":"Nasmyth","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0290","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1128\/MCB.25.16.6990-7004.2005","article-title":"The mSin3A chromatin-modifying complex is essential for embryogenesis and T-cell development","volume":"25","author":"Cowley","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0295","doi-asserted-by":"crossref","first-page":"E3669","DOI":"10.1073\/pnas.1504021112","article-title":"Structural insights into the assembly of the histone deacetylase-associated Sin3L\/Rpd3L corepressor complex","volume":"112","author":"Clark","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2016.12.006_bib0300","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/377397a0","article-title":"Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor","volume":"377","author":"H\u00f6rlein","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.tips.2016.12.006_bib0305","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/377454a0","article-title":"A transcriptional co-repressor that interacts with nuclear hormone receptors","volume":"377","author":"Chen","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.tips.2016.12.006_bib0310","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S1097-2765(03)00454-4","article-title":"Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain","volume":"12","author":"Ahmad","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0315","first-page":"109","article-title":"Deconstructing repression: evolving models of co-repressor action","volume":"11","author":"Perissi","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2016.12.006_bib0320","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1128\/MCB.21.18.6091-6101.2001","article-title":"The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3","volume":"21","author":"Guenther","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0325","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(02)00468-9","article-title":"The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2","volume":"9","author":"Zhang","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nsmb.1983","article-title":"Structural basis for the assembly of the SMRT\/NCoR core transcriptional repression machinery","volume":"18","author":"Oberoi","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0335","doi-asserted-by":"crossref","first-page":"18237","DOI":"10.1074\/jbc.M115.661058","article-title":"Insights into the recruitment of class IIa histone deacetylases (HDACs) to the SMRT\/NCoR transcriptional repression complex","volume":"290","author":"Hudson","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0340","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/cb500235n","article-title":"Chemoproteomics reveals time-dependent binding of histone deacetylase inhibitors to endogenous repressor complexes","volume":"9","author":"Becher","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0345","doi-asserted-by":"crossref","first-page":"11811","DOI":"10.1073\/pnas.1006737107","article-title":"Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells","volume":"107","author":"Farias","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2016.12.006_bib0350","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1535-7163.MCT-14-0980-T","article-title":"Selective inhibition of SIN3 corepressor with avermectins as a novel therapeutic strategy in triple-negative breast cancer","volume":"14","author":"Kwon","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tips.2016.12.006_bib0355","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrd4052","article-title":"Emerging paradigms in GPCR allostery: implications for drug discovery","volume":"12","author":"Wootten","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2016.12.006_bib0360","doi-asserted-by":"crossref","DOI":"10.1039\/c2md20079a","article-title":"The use of phosphate bioisosteres in medicinal chemistry and chemical biology","volume":"3","author":"Elliott","year":"2012","journal-title":"Med. Chem.Commun."},{"key":"10.1016\/j.tips.2016.12.006_bib0365","first-page":"796","article-title":"Kinase inhibitors: an allosteric add on","volume":"10","author":"Foda","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2016.12.006_bib0370","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cbpa.2010.06.176","article-title":"Drug-target residence time: critical information for lead optimization","volume":"14","author":"Lu","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0375","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.bmcl.2014.03.095","article-title":"Hot spot-based design of small-molecule inhibitors for protein\u2013protein interactions","volume":"24","author":"Guo","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2016.12.006_bib0380","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing toward the reality","volume":"21","author":"Arkin","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0385","first-page":"65","article-title":"Regulation of protein\u2013protein interactions using stapled peptides","volume":"5","author":"Robertson","year":"2015","journal-title":"Rep. Org. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0390","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1007\/s13277-016-4868-6","article-title":"Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells","volume":"37","author":"Zhijun","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0395","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejmech.2014.01.056","article-title":"4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors","volume":"76","author":"Baruchello","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0400","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1039\/c3md00285c","article-title":"The structure based design of dual HDAC\/BET inhibitors as novel epigenetic probes","volume":"5","author":"Atkinson","year":"2014","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.tips.2016.12.006_bib0405","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1021\/jm200799p","article-title":"Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors","volume":"55","author":"Guerrant","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0410","doi-asserted-by":"crossref","first-page":"e68915","DOI":"10.1371\/journal.pone.0068915","article-title":"Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma","volume":"8","author":"Wells","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2016.12.006_bib0415","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.chembiol.2009.07.010","article-title":"Chemical probes identify a role for histone deacetylase 3 in Friedreich\u2019s ataxia gene silencing","volume":"16","author":"Xu","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0420","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/leu.2013.231","article-title":"Histone deacetylase 3 as a novel therapeutic target in multiple myeloma","volume":"28","author":"Minami","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.tips.2016.12.006_bib0425","doi-asserted-by":"crossref","first-page":"22211","DOI":"10.1074\/jbc.M110.180224","article-title":"Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells","volume":"286","author":"Huber","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0430","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain","volume":"483","author":"Gr\u00e4ff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tips.2016.12.006_bib0435","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2015.04.013","article-title":"HDAC8: a multifaceted target for therapeutic interventions","volume":"36","author":"Chakrabarti","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2016.12.006_bib0440","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature11316","article-title":"HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle","volume":"489","author":"Deardorff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tips.2016.12.006_bib0445","doi-asserted-by":"crossref","first-page":"e1003645","DOI":"10.1371\/journal.ppat.1003645","article-title":"Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni","volume":"9","author":"Marek","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tips.2016.12.006_bib0450","doi-asserted-by":"crossref","first-page":"21844","DOI":"10.1074\/jbc.M114.558940","article-title":"Insight into the architecture of the NuRD complex: structure of the RbAp48\u2013MTA1 subcomplex","volume":"289","author":"Alqarni","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0455","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1073\/pnas.1015341108","article-title":"p66Alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2\u2013NuRD complex","volume":"108","author":"Gnanapragasam","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2016.12.006_bib0460","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1074\/jbc.M113.512236","article-title":"Probing the dynamic distribution of bound states for methylcytosine-binding domains on DNA","volume":"289","author":"Cramer","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0465","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jmb.2007.11.079","article-title":"Conserved themes in target recognition by the PAH1 and PAH2 domains of the Sin3 transcriptional corepressor","volume":"375","author":"Sahu","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tips.2016.12.006_bib0470","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)00168-9","article-title":"Solution structure of the interacting domains of the Mad\u2013Sin3 complex: implications for recruitment of a chromatin-modifying complex","volume":"103","author":"Brubaker","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.tips.2016.12.006_bib0475","doi-asserted-by":"crossref","first-page":"27814","DOI":"10.1074\/jbc.M111.252494","article-title":"Structure of the 30-kDa Sin3-associated protein (SAP30) in complex with the mammalian Sin3A corepressor and its role in nucleic acid binding","volume":"286","author":"Xie","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2016.12.006_bib0480","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1073\/pnas.0500299102","article-title":"Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors","volume":"102","author":"Codina","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614716301936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614716301936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T23:10:27Z","timestamp":1658531427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614716301936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0165614716301936"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2016.12.006","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Class I Histone Deacetylases in a \u201cComplex\u201d Environment","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2016.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}